Inhibition of triple negative breast cancer metastasis and invasiveness by novel drugs that target epithelial to mesenchymal transition

Invasive breast cancer (BrCa) is predicted to affect 1 in 9 women in a lifetime;1 in 32 will die from this disease. The most aggressive forms of BrCa, basal-like/triple-negative phenotype (TNBC), are challenging to treat and result in higher mortality due high number of metastatic cases. There is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia, Elizabeth, Luna, Ismat, Persad, Kaya L., Agopsowicz, Kate, Jay, David A., West, Frederick G., Hitt, Mary M., Persad, Sujata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175347/
https://www.ncbi.nlm.nih.gov/pubmed/34083676
http://dx.doi.org/10.1038/s41598-021-91344-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175347/
https://www.ncbi.nlm.nih.gov/pubmed/34083676
http://dx.doi.org/10.1038/s41598-021-91344-7

Ejemplares similares